1
|
Ouertani E, Yahyaoui Y, Ghodhbani Z, Letaief-Ksontini F, Gabsi A, Meddeb K, Ayadi M, Mokrani A, Chraiet N, Rais H, Zenzri Y, Ben Mansour H, Mezlini A. 26P Uterine sarcoma: A retrospective Tunisian study of 103 cases. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.04.044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
2
|
Mahjoub N, Ben Salem K, Mokrani A, Mansouri H, Achouri L, Chraiet N, Fehri R. Epidemiological and anatomopathological profile of breast cancer in the region of North-West of Tunisia. Tunis Med 2022; 99:441-448. [PMID: 35244929 PMCID: PMC8734481] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
INTRODUCTION Breast cancer is a common and serious disease. It represents the first cause of mortality and morbidity from cancer of Tunisian women and worldwide. AIM To analyze the clinico-pathological and evolutionary characteristics of the patients followed at the carcinology's pole in the region of the North-West of Tunisia. METHODS We conducted a retrospective descriptive study of 114 patients, who were diagnosed with non metastatic breast cancers over a 6-year period, from January 2011 to December 2016. RESULTS Among the 289 patients treated in the medical carcinology department of the Jendouba regional hospital for invasive breast carcinoma over a period of 6 years, 114 patients had localized breast carcinoma, they were the subject of our study. The average age was 51 years. Nonspecific invasive cancer was the most frequent histological type (95.6%). The mean histological size was 29.3 mm. SBR grade II was most prevalent. Histological lymph node involvement was observed in 50.9%. Lymphovascular invasion was detected in 23.9% of cases and perineural sheaths was detected in 21.9% of cases. The most common molecular subtype was Luminal B. After discussion in a multidisciplinary concertation meeting, the patients received locoregional treatment: surgery, radiotherapy and systemic treatment: chemotherapy, endocrine hormone therapy. After a median follow-up of 45 months, OS and PFS at 5 years were 85.6% and 79.2% respectively. CONCLUSION In the region of the North-West of Tunisia, breast cancer is characterized by its occurrence at a young age, the importance of tumor size, the importance of lymph node involvement, the frequency of inflammatory breast carcinoma and especially by the predominance of the molecular groups Luminal B and HER2 neu.
Collapse
|
3
|
Rashad N, Abdulla M, Farouk M, Elkerm Y, Eid Salem S, Yahia M, Saad AS, Abdel Aziz AH, Refaat G, Awad I, ElNaggar M, Kamal K, Refky B, Abdelkhalek M, Touny A, Kassem L, Shash E, Abdelhay AA, Mahmoud BE, Oualla K, Chraiet N, AwadElkarim H Maki H, Kader YA. Resource Oriented Decision Making for Treatment of Metastatic Colorectal Cancer (mCRC) in a Lower-Middle Income Country: Egyptian Foundation of Medical Sciences (EFMS) Consensus Recommendations 2020. Cancer Manag Res 2022; 14:821-842. [PMID: 35250310 PMCID: PMC8896768 DOI: 10.2147/cmar.s340030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2021] [Accepted: 01/27/2022] [Indexed: 12/24/2022] Open
Abstract
Purpose Colorectal cancer (CRC) is the third most commonly diagnosed cancer worldwide and the second cause of cancer related mortality. Treatment options for patients with metastatic CRC (mCRC) expanded during the last two decades, with introduction of new chemotherapeutic and targeted agents. Egypt is a lower middle-income country; Egyptian health care system is fragmented with wide diversity in drug availability and reimbursement policies across different health care providing facilities. We report the results of consensus recommendations for treatment of patients with metastatic colorectal cancer developed by Egyptian Foundation of Medical Sciences (EFMS), aiming to harmonize clinical practice through structured expert consensus-based recommendations consistent with the national status. EFMS recommendations could be utilized in other countries with similar economic status. Methods EFMS recommendations were developed using a modified Delphi process, with three rounds of voting till the final recommendations were approved. A non-systematic review of literature was conducted before generating the provisional statements. Content experts were asked to vote on some recommendations in two different resource groups (restricted resources and non-restricted resources). External review board of experts from a low income and lower-middle countries voted on the applicability of EFMS recommendations in their countries. Results The current recommendations highlighted the discrepancy in health care between restricted and non-restricted resources with expected survival loss and quality of life deterioration. Access to targeted agents in first line is very limited in governmental institutions, and no access to agents approved for third line in patients who failed oxaliplatin and irinotecan containing regimens for patients treated in restricted resource settings. Conclusion Management of mCRC in developing countries is a challenge. The currently available resource-stratified guidelines developed by international cancer societies represent a valuable decision-making tool, adaptation to national status in each country based on healthcare system status is required.
Collapse
Affiliation(s)
- Noha Rashad
- Medical Oncology Department, Faculty of Medicine, Suez University, Suez, Egypt
- Correspondence: Noha Rashad, Medical Oncology Department, Faculty of Medicine, Suez University, Faisal, Suez Governorate, Egypt, Tel +20 1225157339, Email
| | - Mohamed Abdulla
- Clinical Oncology and Nuclear Medicine Department, Kasr Al-Aini Medical School, Cairo University, Cairo, Egypt
| | - Mohamed Farouk
- Department of Clinical Oncology, Faculty of Medicine, Alexandria University, Alexandria, Egypt
| | - Yasser Elkerm
- Department of Cancer Management and Research, Medical Research Institute Hospital, University of Alexandria, Alexandria, Egypt
| | - Salem Eid Salem
- Department of Medical Oncology, National Cancer Institute (NCI), Cairo University, Cairo, Egypt
| | - Maha Yahia
- Department of Medical Oncology, National Cancer Institute (NCI), Cairo University, Cairo, Egypt
| | - Amr S Saad
- Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
| | - Ahmed Hassan Abdel Aziz
- Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
| | - Ghada Refaat
- Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
| | - Ibrahim Awad
- Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt
| | - Maha ElNaggar
- Clinical Oncology Department, Assiut University Hospital, Assiut, Egypt
| | - Khaled Kamal
- Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
| | - Basel Refky
- Department of Surgical Oncology, Oncology Center Mansoura University, Mansoura, Egypt
| | - Mohamed Abdelkhalek
- Department of Surgical Oncology, Oncology Center Mansoura University, Mansoura, Egypt
| | - Ahmed Touny
- Department of Surgical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt
| | - Loay Kassem
- Clinical Oncology and Nuclear Medicine Department, Kasr Al-Aini Medical School, Cairo University, Cairo, Egypt
| | - Emad Shash
- Department of Medical Oncology, National Cancer Institute (NCI), Cairo University, Cairo, Egypt
| | | | | | - Karima Oualla
- Medical Oncology Department, Hassan II University Hospital Sidi Mohamed Ben Abdellah University, Fes, Morocco
| | - Nesrine Chraiet
- Medical Oncology Department, Salah Azaiez National Cancer Institute, Tunis, Tunisia
| | | | - Yasser Abdel Kader
- Clinical Oncology and Nuclear Medicine Department, Kasr Al-Aini Medical School, Cairo University, Cairo, Egypt
| |
Collapse
|
4
|
Ben Abdallah I, Ben Nasr S, Chourabi C, Boukhris M, Ben Abdallah I, Zribi A, Fendri S, Balti M, Fehri W, Chraiet N, Haddaoui A. The Predictive Value of 2D Myocardial Strain for Epirubicin-Induced Cardiotoxicity. J Oncol 2020; 2020:5706561. [PMID: 33335549 PMCID: PMC7723482 DOI: 10.1155/2020/5706561] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/26/2020] [Revised: 09/06/2020] [Accepted: 11/11/2020] [Indexed: 11/18/2022]
Abstract
INTRODUCTION Although epirubicin has significantly improved outcome in breast cancer (BC) patients, it is responsible for myocardial dysfunction that affects patients' quality of life. The use of 2D global longitudinal strain (GLS) has been reported to detect early myocardial dysfunction. The aim of this study was to evaluate how GLS changes can predict cardiotoxicity. METHODS We conducted a prospective study from March 2018 to March 2020 on 66 patients with no cardiovascular risk factors, who presented with BC and received epirubicin. We measured left ventricular ejection fraction (LVEF) and GLS before chemotherapy, at three months (T3), and at 12 months (T12) from the last epirubicin infusion. Chemotherapy-Related-Cardiac-Dysfunction (CTRCD) was defined as a decrease of 10% in LVEF to a value below 53% according to ASE and EACI 2014 expert consensus. RESULTS The mean age at diagnosis was 47 ± 9 years old. At baseline, median LVEF was 70% and median GLS was -21%. Shortly after chemotherapy completion, two patients presented with symptomatic heart failure while asymptomatic CTRCD was revealed in three other patients at T12. Three months after the last epirubicin infusion, median LVEF was 65%, median GLS was -19%, and median GLS variation was 5%. However, in patients who presented with subsequent CTRCD, median GLS at T3 was -16% and median GLS variation was 19% (p=0.002 and p < 0.001, respectively, when compared to patients who did not develop cardiotoxicity). Persistent GLS decrease at T3 was an independent predictor of CTRCD at T12. Age and left-sided thoracic irradiation did not increase the risk of cardiotoxicity in our study while the cumulative dose of epirubicin significantly affected cardiologic findings (p=0.001). CONCLUSION This was the first North African study that assesses the value of measuring GLS to early detect cardiotoxicity. Patients whose GLS remained decreased after 3 months from anthracyclines-base chemotherapy had an increased risk for developing subsequent CTRCD. Further studies with larger sample size are warranted to identify the best cardioprotective molecules to be initiated in these patients before LVEF declines.
Collapse
Affiliation(s)
- Ichrak Ben Abdallah
- Department of Medical Oncology, Military Hospital of Tunis, Université de Tunis El Manar, Faculté de Médecine de Tunis, Tunis 1007, Tunisia
| | - Sonia Ben Nasr
- Department of Medical Oncology, Military Hospital of Tunis, Université de Tunis El Manar, Faculté de Médecine de Tunis, Tunis 1007, Tunisia
| | - Chadia Chourabi
- Department of Cardiology, Military Hospital of Tunis Université de Tunis El Manar, Faculté de Médecine de Tunis, Tunis 1007, Tunisia
| | - Marouane Boukhris
- Division of Cardiology, Centre Hospitalier de l'université de Montréal, Montreal, Québec, Canada
| | - Israa Ben Abdallah
- Department of Business Analytics, Tunis Business School, El Mourouj, Tunisia
| | - Aref Zribi
- Department of Medical Oncology, Military Hospital of Tunis, Université de Tunis El Manar, Faculté de Médecine de Tunis, Tunis 1007, Tunisia
| | - Sana Fendri
- Department of Medical Oncology, Military Hospital of Tunis, Université de Tunis El Manar, Faculté de Médecine de Tunis, Tunis 1007, Tunisia
| | - Mehdi Balti
- Department of Medical Oncology, Military Hospital of Tunis, Université de Tunis El Manar, Faculté de Médecine de Tunis, Tunis 1007, Tunisia
| | - Wafa Fehri
- Department of Cardiology, Military Hospital of Tunis Université de Tunis El Manar, Faculté de Médecine de Tunis, Tunis 1007, Tunisia
| | - Nesrine Chraiet
- Department of Medical Oncology, Université de Tunis El Manar, Faculté de Médecine de Tunis, Tunis 1007, Tunisia
| | - Abderrazek Haddaoui
- Department of Medical Oncology, Military Hospital of Tunis, Université de Tunis El Manar, Faculté de Médecine de Tunis, Tunis 1007, Tunisia
| |
Collapse
|
5
|
Gabsi A, N. Jbali, Yahiaoui Y, Letaief-Ksontini F, Mghirbi F, A. Mokrani, Meddeb K, Ayadi M, Rais H, Chraiet N, Mezlini A. 1832P Nutritional status assessment in patients followed for head and neck cancer. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.1479] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
6
|
Meddeb K, Karray W, Guermazi F, Hmida L, Mokrani A, Yahyaoui Y, Letaief F, Gabsi A, Ayadi M, Chraiet N, Raies H, Mezlini A. An exceptional case of a duodenal metastasis from a nasopharyngeal carcinoma. Otolaryngology Case Reports 2020. [DOI: 10.1016/j.xocr.2020.100163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
7
|
Ben Abdallah I, Ben Nasr S, Chourabi C, Boukhris M, Zribi A, S. Fendri, Balti M, W. Fehri, Chraiet N, Haddaoui A. 1506P The predictive value of 2-D myocardial strain for epirubicin-induced cardiotoxicity. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
8
|
Souilhi A, Gabsi A, Letaief-Ksontini F, Chraiet N, Yahiaoui Y, Mghirbi F, Mokrani A, Meddeb K, Ayadi M, Rais H, Mezlini A. 1572P Psychological impact of the COVID-19 pandemic on health care workers in oncology in Tunisia. Ann Oncol 2020. [PMCID: PMC7506482 DOI: 10.1016/j.annonc.2020.08.2055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
9
|
Nefzi R, BATTI R, Khrouf S, Krir W, Chraiet N, Rais H, Mezlini A, Oumaya A. 1575P Psychological burden in mothers of children with cancer. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.2058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
10
|
Gabsi A, Zenzri Y, Sahraoui G, Ben Brahim I, Cherif M, Yahyaoui Y, Chraiet N, Mrad K, Chedly A, Ben Maamer A, Mezlini A. Gastric EBV-positive mucocutaneous ulcer: A rare pathological entity. Clin Case Rep 2020; 8:1130-1133. [PMID: 32695342 PMCID: PMC7364068 DOI: 10.1002/ccr3.2837] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2019] [Revised: 02/19/2020] [Accepted: 03/20/2020] [Indexed: 11/17/2022] Open
Abstract
The gastric location of EBVMCU is extremely rare. The pathology examination and immunochemistry are mandatory for the diagnosis. It is essential that physicians be aware of this new entity to accurately diagnose and handle this disease.
Collapse
Affiliation(s)
- Azza Gabsi
- Medical Oncology DepartmentFaculty of Medicine of TunisEl Manar UniversitySalah Azaiez InstituteTunisTunisia
| | - Yosr Zenzri
- Medical Oncology DepartmentFaculty of Medicine of TunisEl Manar UniversitySalah Azaiez InstituteTunisTunisia
| | - Ghada Sahraoui
- Pathology DepartmentFaculty of Medicine of TunisEl Manar UniversitySalah Azaiez InstituteTunisTunisia
| | - Ihsen Ben Brahim
- Pathology DepartmentFaculty of Medicine of TunisEl Manar UniversityHabib Thameur HospitalTunisTunisia
| | - Mouna Cherif
- Surgery departmentFaculty of Medicine of TunisEl Manar UniversityHabib Thameur HospitalTunisTunisia
| | - Yosra Yahyaoui
- Medical Oncology DepartmentFaculty of Medicine of TunisEl Manar UniversitySalah Azaiez InstituteTunisTunisia
| | - Nesrine Chraiet
- Medical Oncology DepartmentFaculty of Medicine of TunisEl Manar UniversitySalah Azaiez InstituteTunisTunisia
| | - Karima Mrad
- Pathology DepartmentFaculty of Medicine of TunisEl Manar UniversitySalah Azaiez InstituteTunisTunisia
| | - Achraf Chedly
- Pathology DepartmentFaculty of Medicine of TunisEl Manar UniversityHabib Thameur HospitalTunisTunisia
| | - Anis Ben Maamer
- Surgery departmentFaculty of Medicine of TunisEl Manar UniversityHabib Thameur HospitalTunisTunisia
| | - Amel Mezlini
- Medical Oncology DepartmentFaculty of Medicine of TunisEl Manar UniversitySalah Azaiez InstituteTunisTunisia
| |
Collapse
|
11
|
Charfi L, Houcine Y, Yahyaoui Y, Sahraoui G, Chraiet N, Mrad K, Doghri R. Primary breast Anaplasic Lymphoma Kinase-positive anaplastic lymphoma in an adolescent. Breast J 2020; 26:2068-2069. [PMID: 32564443 DOI: 10.1111/tbj.13949] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2020] [Revised: 06/02/2020] [Accepted: 06/02/2020] [Indexed: 12/01/2022]
Affiliation(s)
- Lamia Charfi
- Pathology Department, Faculty of Medicine of Tunis, Salah Azaiez Institute, El Manar University, Tunis, Tunisia
| | - Yoldez Houcine
- Pathology Department, Faculty of Medicine of Tunis, Salah Azaiez Institute, El Manar University, Tunis, Tunisia
| | - Yosra Yahyaoui
- Medical Oncology Department, Faculty of Medicine of Tunis, Salah Azaiez Institute, El Manar University, Tunis, Tunisia
| | - Gada Sahraoui
- Pathology Department, Faculty of Medicine of Tunis, Salah Azaiez Institute, El Manar University, Tunis, Tunisia
| | - Nesrine Chraiet
- Medical Oncology Department, Faculty of Medicine of Tunis, Salah Azaiez Institute, El Manar University, Tunis, Tunisia
| | - Karima Mrad
- Pathology Department, Faculty of Medicine of Tunis, Salah Azaiez Institute, El Manar University, Tunis, Tunisia
| | - Raoudha Doghri
- Pathology Department, Faculty of Medicine of Tunis, Salah Azaiez Institute, El Manar University, Tunis, Tunisia
| |
Collapse
|
12
|
Chraiet N, Zenzri Y, Bouaziz H, Sassi I, Guebsi A, Kamoun S, Rahal K, Mezlini A. Generalized cutaneous metastases of breast cancer: An uncommon presentation. Clin Case Rep 2020; 8:667-671. [PMID: 32274032 PMCID: PMC7141747 DOI: 10.1002/ccr3.2693] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2019] [Revised: 12/16/2019] [Accepted: 01/09/2020] [Indexed: 11/27/2022] Open
Abstract
Cutaneous metastases are rare and represent a sign of poor prognosis. They are a sign of widespread disease. Breast cancer is the most common neoplasm leading to their appearance. Palliative care is the treatment of choice.
Collapse
Affiliation(s)
- Nesrine Chraiet
- Medical Oncology DepartmentFaculty of Medicine of TunisSalah Azaiez InstituteEl Manar UniversityTunisTunisia
| | - Yosr Zenzri
- Medical Oncology DepartmentFaculty of Medicine of TunisSalah Azaiez InstituteEl Manar UniversityTunisTunisia
| | - Hanen Bouaziz
- Surgical Oncology DepartmentFaculty of Medicine of TunisSalah Azaiez InstituteEl Manar UniversityTunisTunisia
| | - Imen Sassi
- Surgical Oncology DepartmentFaculty of Medicine of TunisSalah Azaiez InstituteEl Manar UniversityTunisTunisia
| | - Azza Guebsi
- Medical Oncology DepartmentFaculty of Medicine of TunisSalah Azaiez InstituteEl Manar UniversityTunisTunisia
| | - Salma Kamoun
- Pathology DepartmentFaculty of Medicine of TunisSalah Azaiez InstituteEl Manar UniversityTunisTunisia
| | - Khaled Rahal
- Surgical Oncology DepartmentFaculty of Medicine of TunisSalah Azaiez InstituteEl Manar UniversityTunisTunisia
| | - Amel Mezlini
- Medical Oncology DepartmentFaculty of Medicine of TunisSalah Azaiez InstituteEl Manar UniversityTunisTunisia
| |
Collapse
|
13
|
Batti R, Mokrani A, Rachdi H, Raies H, Touhami O, Ayadi M, Meddeb K, Letaief F, Yahiaoui Y, Chraiet N, Mezlini A. Gestational trophoblastic neoplasia: experience at Salah Azaiez Institute. Pan Afr Med J 2019; 33:121. [PMID: 31489099 PMCID: PMC6711693 DOI: 10.11604/pamj.2019.33.121.13897] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2017] [Accepted: 04/14/2019] [Indexed: 02/07/2023] Open
Abstract
Gestational trophoblastic disease (GTD) develops from abnormal cellular proliferation of trophoblasts following fertilization. It includes benign trophoblastic disease (hydatidiform moles (HM)) and the malignant trophoblastic diseases or gestational trophoblastic neoplasia (GTN). The frequency of the GTD in Tunisia is one per 918 deliveries. The aim of this study is to analyze the clinical characteristics, treatment and outcomes of GTD at Salah Azaiez Institute (ISA). Medical records of women diagnosed with GTD at ISA from January 1st, 1981 to December 31st, 2012 were retrospectively reviewed. FIGO score was determined retrospectively for patients treated before 2002. One hundred and nine patients with GTN were included. Patients presented with metastases at 43% of cases. The most common metastatic sites were lung (30%) and vagina (13%). Fifty six (56 (51%) patients had low-risk and 21 (19%) cases had high-risk, the FIGO score was not assessed in 32 cases. After a median follow-up of 46 months, 21 patients were lost to follow-up, 12 patients died, 19 progressed and 8 relapsed. At 10 years, the OS rate was 85% and the PFS rate 79%. OS was significantly influenced by the presence of metastases at presentation (M0 100 % vs. Metastatic 62 %; p < 0.0001), FIGO stage (I-II 100% VS 61% and 65% for stage III and IV; p < 0.001), FIGO score (low-risk 99 % vs. high-risk 78 %; p < 0.001). GTN is a significant source of maternal morbidity with increased risk of mortality from complications if not detected early and treated promptly.
Collapse
Affiliation(s)
- Rim Batti
- Department of Medical Oncology at Salah Azaiz Institute, Tunis, Tunisia
| | - Amina Mokrani
- Department of Medical Oncology at Salah Azaiz Institute, Tunis, Tunisia
| | - Haifa Rachdi
- Department of Medical Oncology at Salah Azaiz Institute, Tunis, Tunisia
| | - Henda Raies
- Department of Medical Oncology at Salah Azaiz Institute, Tunis, Tunisia
| | - Omar Touhami
- "C" Department of Obstetrics and Gynecology, Tunis Maternity and Neonatology Center, Tunis, Tunisia
| | - Mouna Ayadi
- Department of Medical Oncology at Salah Azaiz Institute, Tunis, Tunisia
| | - Khadija Meddeb
- Department of Medical Oncology at Salah Azaiz Institute, Tunis, Tunisia
| | - Feryel Letaief
- Department of Medical Oncology at Salah Azaiz Institute, Tunis, Tunisia
| | - Yosra Yahiaoui
- Department of Medical Oncology at Salah Azaiz Institute, Tunis, Tunisia
| | - Nesrine Chraiet
- Department of Medical Oncology at Salah Azaiz Institute, Tunis, Tunisia
| | - Amel Mezlini
- Department of Medical Oncology at Salah Azaiz Institute, Tunis, Tunisia
| |
Collapse
|
14
|
Rachdi H, Mokrani A, Batti R, Raies H, Touhami O, Ayadi M, Meddeb K, Letaief F, Yahiaoui Y, Chraiet N, Mezlini A. Gestational Trophoblastic Neoplasia: A Tunisian Multicenter Study. Asian Pac J Cancer Care 2019. [DOI: 10.31557/apjcc.2019.4.2.59-64] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
Gestational trophoblastic disease (GTD) develops from abnormal cellular proliferation of trophoblasts following fertilization. It includes benign trophoblastic disease (hydatidiform moles (HM) and the malignant trophoblastic diseases or gestational trophoblastic neoplasia (GTN). The frequency of the GTD in Tunisia is one per 918 deliveries. The aim of this study is to analyze the clinical characteristics, treatment and outcomes of GTD at Salah Azaiez Institute (ISA). Medical records of women diagnosed with GTD at ISA from January 1, 1981 to December 31, 2012 were retrospectively reviewed. FIGO (International Federation of Gynecology and Obstetrics) score was determined retrospectively for patients treated before 2002 One hundred and nine patients with GTN were included. Patients presented with metastases at 43% of cases. The most common metastatic sites was lung (30%) and vagina (13%). 56 (51%) patients had low-risk and 21 (19%) cases had high-risk, the FIGO score was not assessed in 32 cases. After a median follow-up of 46 months, 21 patients were lost to follow-up, 12 patients died, 19 progressed and 8 relapsed. At 10 years, the OS rate was 85% and the PFS rate 79%. OS was significantly influenced by the presence of metastases at presentation (M0 100 % vs. Metastatic 62 %; p < 0.0001), FIGO stage (I-II 100% VS 61% and 65% for stage III and IV; p < 0.001), FIGO score (low-risk 99 % vs. high-risk 78 %; p < 0.001). GTN is a significant source of maternal morbidity with increased risk of mortality from complications if not detected early and treated promptly.
Collapse
|
15
|
Aarab J, Abbess I, Abdalla F, Abdelaziz Z, Abdelfattah S, Abdelli I, Abdelmajid K, Abdelsselem Z, Abdelwahed N, Abdessayed N, Abid B, Abid K, Abidi R, Abudabbous A, Abujanah S, Aburwais A, Acacha E, Acharfi N, Affes N, Aftis R, Ahalli I, Aid M, Aissaoui D, Alaoui A, Alaoui M, Albatran S, Mamdouh A, Alkikkli R, Allam A, Aloulou S, Alqawi O, Alragig MA, Alsharksi A, Amaadour KOL, Amaadour L, Ameziane N, Ammari A, Ammour H, Amrane R, Annad N, Aouati E, Aouichat S, Aouragh S, Arifi S, Astra M, Atassi M, Ati N, Atoui K, Atreche L, Ayachi S, Ayadi I, Ayadi MA, Ayadi M, Ayari J, Ayed H, Ayed K, Ayedi H, Ayedi I, Azegrar M, Azzouz H, Babdalla F, Bachiri R, Bachiri Z, Baghdad M, Bahloul R, Bahouli A, Bahri M, Baississ I, Bakkali H, Balti M, Baraket O, Bargaoui H, Batti R, Bedioui A, Begag R, Behourah Z, Belaid I, Belaïd A, Ben Abdallah A, Ben Abdallah I, Ben Ahmed S, Ben Ahmed T, Ben Azaiz M, Ben Chehida MA, Ben Fatma L, Ben Ghachem D, Ben Ghachem T, Ben Hassouna J, Ben Hmida S, Ben Nasr S, Ben Nejima D, Ben Rahal K, Ben Rejeb M, Ben Rhouma S, Ben Safta I, Ben Salem A, Ben Zargouna Y, Benabdallah I, Benabdella H, Benabdessalem MZ, Benahmed K, Benahmed S, Benameur H, Benasr S, Benbrahim F, Benbrahim W, Benbrahim Z, Benchehida M, Bencheikh Y, Bendhiab T, Benfatma L, Bengueddach A, Benhami M, Benhassouna J, Benhbib W, Benjaafar N, Benkali R, Benkridis W, Benlaloui A, Benmaitig M, Benmansour A, Benmouhoub M, Benna F, Benna H, Benna M, Benna M, Bennabdellah H, Benrahal K, Bensafta I, Bensalah H, Bensalem A, Bensaud M, Benslama R, Benyoub M, Benzid K, Bergaoui H, Beroual M, Berrad S, Berrazaga Y, Bezzaz Z, Bhiri H, Bibi M, Binous MY, Blel A, Boder JM, Bouaouina N, Bouaziz H, Bouchoucha S, Boudawara T, Boudawara Z, Bouderbala A, Bouhali R, Bouhani M, Boujarnija R, Boujelben S, Boujelbene N, Boukerzaza I, Boukhari H, Boulfoul W, Boulma R, Boumansour N, Bouned A, Bounedjar A, Bouraoui I, Bouraoui S, Bourigua R, Bourmech M, Bousaffa H, Bousahba A, Bousrih C, Boussarsar A, Boussen H, Boutayeb S, Bouzaidi K, Bouzaiene F, Bouzaiene H, Bouzerzour Z, Bouzid K, Bouzid N, Bouzidi D, Bouzidi W, Bouzouita A, Brahimi S, Brahmia A, Buhmeida A, Chaaben K, Chaabouni H, Chaabouni M, Chaabène K, Chaari H, Chaari I, Chaari M, Chabchoub I, Chabeene K, Chaker K, Chakroun M, Charfi M, Charfi S, Chargui R, Charles M, Chebil M, Cheikchouk K, Chelly B, Chelly I, Cheraiet N, Cherif A, Cherif M, Cherifi A, Chikhrouhou T, Chikouche A, Chirouf A, Chraiet N, Collan Y, Cui Z, Dabbebi H, Daldoul A, Damouche I, Daoud H, Daoud N, Daoued J, Darif K, Darwish DO, Derbouz Z, Derouiche A, Dhibe TT, Dhibet T, Djallaoui A, Djami N, Djebbes K, Djedi H, Djeghim S, Djellali L, Djellaoui A, Djilat K, Djouabi R, Doumbia H, Drah M, Dridi M, Hsairi M, Elabbassi S, Elallia F, Elati Z, Elattassi M, Elbenna H, Elfagieh MA, Elfaitori O, Elfannas H, Elghali A, Elghali MA, Elgonti S, Elhadj OE, Elhazzaz R, Elkacemi H, Elkinany K, Elkissi Y, Elloumi F, Elmaalel O, Elmajjaou IS, Elmajjaoui S, Elmhabrech H, Elmrabet F, Elsaghayer WA, Elzagheid A, Emaetig F, Erraichi H, Essid M, Ewshah N, Ezzairi F, Faleh R, Fallah S, Farag AL, Farhat L, Fehri R, Feki J, Fendri S, Fendri S, Fessi Z, Filali T, Fissah A, Fourati M, Fourati N, Frikha M, Fuchs CS, Gabssi A, Gachi F, Gadria S, Gammoudi A, Ganzoui I, Gargoura A, Ghaddabb I, Gharbi I, Gharbi M, Ghazouani E, Gheriani N, Ghorbel A, Ghorbel L, Ghozi A, Ghrissi R, Gouader A, Goucha A, Guebsi A, Guellil I, Guermazi F, Guesmi S, Guetari W, Habak N, Haddad A, Haddad S, Haddaoui A, Hadef I, Hader AF, Hadiji A, Hadjarab F, Hadoussa M, Hadoussa N, Hafsa C, Hafsia M, Hajji A, Hajmansour M, Hamdi S, Hamici Z, Hamida S, Hamila F, Hamissa S, Hammouda B, Haouet S, Harhira I, Haroun A, Hassouni K, Hdiji A, Hechiche M, Hejjane L, Hellal C, Henni M, Herbegue K, Hichami L, Hikem M, Hmad A, Hmida L, Hmissa S, Hochlaf M, Houas A, Houhani M, Huwidi A, Ian C, Ibrahim BN, Ibrahim NY, Idir H, Issaoui D, Itaimi A, Izem AE, Jaidane O, Jamel D, Jamous H, Jarrar M, Jarrar MS, Jarray S, Jebsi M, Jmal H, Juwid A, Kaabia O, Kablouti A, Kacem I, Kacem K, Kaid MY, Kallel M, Kallel R, Kammoun H, Kari S, Karrit S, Kchir H, Kchir N, Kebdani T, Kechad N, Kehili H, Kerboua E, Keskes H, Kessi NN, Khababa N, Khaldi H, Khanfir A, Khater B, Khelif A, Khemiri S, Khennouf K, Khouni H, Khrouf S, Kmira Z, Kochbati L, Korbi A, Kouadri N, Kouhen F, Krarti M, Handoussa M, Hsu Y, Laakom O, Laato M, Labidi S, Lahlali F, Lahmidi A, Lalaoui A, Lamia N, Lamri A, Letaief F, Letaief MR, Aldehmani M, Rafael A, Liepa AM, Limaiem F, Limam K, Loughlimi H, Ltaief F, Maamouri N, Mabrouk M, Madouri R, Mahjoub N, Mahjoubi Z, Mahrsi M, Makrem H, Mallek W, Manitta M, Mansoura L, Mansouri H, Maoua M, Maoui W, Marouene C, Marzouk K, Masmoudi S, May F, Meddeb I, Meddeb K, Meddour S, Medhioub F, Mejri N, Melizi MR, Mellas N, Melliti R, Melzi A, Merair N, Merrouki FZ, Mersali C, Messalbi O, Messaoudi L, Messioud S, Messoudi K, Mestiri S, Mezlini A, Mezlini A, Mghirbi F, Mhabrech H, Mhiri A, Midoun N, Milud R, Missaoui B, Mnasser A, Mnejja W, Mokni M, Mokrani A, Mokrani M, Moujahed R, Moukasse Y, Mouzount A, Mrad K, Mraidha MH, Mrizak N, Mzali R, Mzid Y, M'ghirbi F, Nakhli A, Nasr C, Nasri S, Noubigh G, Nouha D, Nouia L, Nouira Y, Noureddine A, Nouri O, Ohtsu A, Ouahbi H, Oualla K, Ouanes Y, Ouaz H, Ouikene A, Ouldbessi N, Parker I, Pyrhonen S, Rachdi H, Rahal K, Rahal K, Rahoui M, Raies H, Rameh S, Reguieg K, Rejab H, Rejiba R, Rhim MS, Riahi S, Rouimel N, Saad Saoud N, Saadi K, Saadi M, Sadou A, Saguem I, Sahnoun T, Sahnoune H, Sakhri S, Sallemi A, Sassi A, Sbika W, Sedkaoui C, Sefiane S, Sellami A, Seppo P, Sfaoua H, Sghaier S, Shagan A, Siala W, Slim I, Slimene M, Soltani S, Souilah S, Souissi M, Sriha Badreddine B, Swaisi Y, Taibi A, Taktak T, Talbi G, Talha SW, Talima SM, Tbessi S, Tebani N, Tebra S, Tebramrad S, Telaijia D, Tenni A, Tolba A, Topov Y, Touil K, Toumi N, Toumi W, Tounsi N, Trigui A, Trigui R, Triki W, Walha M, Werda I, Yacoub H, Yahyaoui Y, Yaich A, Yaici R, Yamouni M, Yeddes I, Yekrou D, Yousfi M, Yousfi N, Youssfi MA, Zaabar L, Zaied S, Zaim I, Zakhama W, Zayed S, Zehani A, Zemni I, Zenzri Y, Zeraoula S, Zouiten O, Zoukar O, Zrafi W, Zribi A, Zubia N. Poster abstracts of the 18th Pan Arab Cancer Congress. TUNISIA. April 19-21, 2018. Tunis Med 2018; 96:177-182. [PMID: 30430520] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Subscribe] [Scholar Register] [Indexed: 09/28/2022]
|
16
|
Letaief-Ksontini F, Dorra T, Masmoudi S, Meddeb K, Mokrani A, Yahyaoui Y, Gabsi A, Ayadi M, Chraiet N, Raies H, Mezlini A. Impact of cancer on the quality of life of Tunisian pediatric patients. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy296.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
17
|
Gabsi A, Yahiaoui Y, Zenhani A, Herbegue K, Meddeb K, Mokrani A, Letaief F, Ayadi M, Rais H, Chraiet N, Haouet S, Mezlini A. Ureteral metastasis in carcinoma of the breast. Urol Case Rep 2018; 21:38-40. [PMID: 30202731 PMCID: PMC6128026 DOI: 10.1016/j.eucr.2018.08.012] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2018] [Accepted: 08/15/2018] [Indexed: 11/20/2022] Open
Affiliation(s)
- Azza Gabsi
- Medical Oncology Department, Salah Azaiez Institute, Tunis, Tunisia
| | - Yosra Yahiaoui
- Medical Oncology Department, Salah Azaiez Institute, Tunis, Tunisia
| | - Alia Zenhani
- Department of Pathology, Rabta Hospital, Faculty of Medicine, Tunis, Tunisia
| | | | - Khedija Meddeb
- Medical Oncology Department, Salah Azaiez Institute, Tunis, Tunisia
| | - Amina Mokrani
- Medical Oncology Department, Salah Azaiez Institute, Tunis, Tunisia
| | - Feryel Letaief
- Medical Oncology Department, Salah Azaiez Institute, Tunis, Tunisia
| | - Mouna Ayadi
- Medical Oncology Department, Salah Azaiez Institute, Tunis, Tunisia
| | - Henda Rais
- Medical Oncology Department, Salah Azaiez Institute, Tunis, Tunisia
| | - Nesrine Chraiet
- Medical Oncology Department, Salah Azaiez Institute, Tunis, Tunisia
| | - Slim Haouet
- Department of Pathology, Rabta Hospital, Faculty of Medicine, Tunis, Tunisia
| | - Amel Mezlini
- Medical Oncology Department, Salah Azaiez Institute, Tunis, Tunisia
| |
Collapse
|
18
|
Mokrani A, Guermazi F, Meddeb K, Hadj Kacem LB, Chakroun M, Yahyaoui Y, Letaief F, Gabsi A, Bouzouita A, Ayadi M, Chraiet N, Raies H, Rammeh S, Chebil M, Mezlini A. Liposarcoma of the spermatic cord: A case report and review of literature. Urol Case Rep 2018; 21:19-20. [PMID: 30140612 PMCID: PMC6105755 DOI: 10.1016/j.eucr.2018.07.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2018] [Accepted: 07/04/2018] [Indexed: 11/16/2022] Open
Affiliation(s)
- Amina Mokrani
- Department of Oncology, Salah Azaiez Institute, Faculty of Medicine of Tunis, Boulevard 9 Avril, Tunis El Manar University, Tunis, France
| | - Fatma Guermazi
- Department of Oncology, Salah Azaiez Institute, Faculty of Medicine of Tunis, Boulevard 9 Avril, Tunis El Manar University, Tunis, France
| | - Khedija Meddeb
- Department of Oncology, Salah Azaiez Institute, Faculty of Medicine of Tunis, Boulevard 9 Avril, Tunis El Manar University, Tunis, France
| | - Linda Bel Hadj Kacem
- Department of Pathology, Charles Nicolle Hospital, Faculty of Medicine of Tunis, Boulevard 9 Avril, Tunis El Manar University, Tunis, France
| | - Marouene Chakroun
- Department of Urology, Charles Nicolle Hospital, Faculty of Medicine of Tunis, Boulevard 9 Avril, Tunis El Manar University, Tunis, France
| | - Yosra Yahyaoui
- Department of Oncology, Salah Azaiez Institute, Faculty of Medicine of Tunis, Boulevard 9 Avril, Tunis El Manar University, Tunis, France
| | - Feriel Letaief
- Department of Oncology, Salah Azaiez Institute, Faculty of Medicine of Tunis, Boulevard 9 Avril, Tunis El Manar University, Tunis, France
| | - Azza Gabsi
- Department of Oncology, Salah Azaiez Institute, Faculty of Medicine of Tunis, Boulevard 9 Avril, Tunis El Manar University, Tunis, France
| | - Abderrazek Bouzouita
- Department of Urology, Charles Nicolle Hospital, Faculty of Medicine of Tunis, Boulevard 9 Avril, Tunis El Manar University, Tunis, France
| | - Mouna Ayadi
- Department of Oncology, Salah Azaiez Institute, Faculty of Medicine of Tunis, Boulevard 9 Avril, Tunis El Manar University, Tunis, France
| | - Nesrine Chraiet
- Department of Oncology, Salah Azaiez Institute, Faculty of Medicine of Tunis, Boulevard 9 Avril, Tunis El Manar University, Tunis, France
| | - Henda Raies
- Department of Oncology, Salah Azaiez Institute, Faculty of Medicine of Tunis, Boulevard 9 Avril, Tunis El Manar University, Tunis, France
| | - Soumaya Rammeh
- Department of Pathology, Charles Nicolle Hospital, Faculty of Medicine of Tunis, Boulevard 9 Avril, Tunis El Manar University, Tunis, France
| | - Mohamed Chebil
- Department of Urology, Charles Nicolle Hospital, Faculty of Medicine of Tunis, Boulevard 9 Avril, Tunis El Manar University, Tunis, France
| | - Amel Mezlini
- Department of Oncology, Salah Azaiez Institute, Faculty of Medicine of Tunis, Boulevard 9 Avril, Tunis El Manar University, Tunis, France
| |
Collapse
|
19
|
Batti R, Letaief F, Rachdi H, Zidi A, Sghaier S, Ayadi M, Meddeb K, Mokrani A, Yahyaoui Y, Raies H, Chraiet N, Mezlini A. [Synchronous pulmonary and lachrymal glands involvement by MALT lymphoma]. Pan Afr Med J 2018; 29:198. [PMID: 30061976 PMCID: PMC6061860 DOI: 10.11604/pamj.2018.29.198.14007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2017] [Accepted: 03/02/2018] [Indexed: 11/25/2022] Open
Abstract
Les lymphomes pulmonaires primitifs sont des tumeurs rares représentant moins de 1% des tumeurs malignes du poumon. La forme la plus fréquente est le lymphome de type Mucosa-Associated Lymphoid Tissue (MALT). L'atteinte oculaire est aussi rare et elle est dans la plupart du temps localisée dans les glandes lacrymales. Nous rapportons l'observation d'un patient ayant présenté un lymphome pulmonaire de type MALT associé à une atteinte synchrone des glandes lacrymales. Cette observation illustre les aspects cliniques, radiologiques et évolutifs de cette entité qui sont peu spécifiques.
Collapse
Affiliation(s)
- Rim Batti
- Service d'Oncologie Médicale, Institut Salah Azaiz, Tunis, Tunisie
| | - Feryel Letaief
- Service d'Oncologie Médicale, Institut Salah Azaiz, Tunis, Tunisie
| | - Haifa Rachdi
- Service d'Oncologie Médicale, Institut Salah Azaiz, Tunis, Tunisie
| | - Asma Zidi
- Service de Radiologie, Institut Salah Azaiez, Tunis, Tunisie
| | - Sonia Sghaier
- Service de Radiologie, Institut Salah Azaiez, Tunis, Tunisie
| | - Mouna Ayadi
- Service d'Oncologie Médicale, Institut Salah Azaiz, Tunis, Tunisie
| | - Khadija Meddeb
- Service d'Oncologie Médicale, Institut Salah Azaiz, Tunis, Tunisie
| | - Amina Mokrani
- Service d'Oncologie Médicale, Institut Salah Azaiz, Tunis, Tunisie
| | - Yosra Yahyaoui
- Service d'Oncologie Médicale, Institut Salah Azaiz, Tunis, Tunisie
| | - Henda Raies
- Service d'Oncologie Médicale, Institut Salah Azaiz, Tunis, Tunisie
| | - Nesrine Chraiet
- Service d'Oncologie Médicale, Institut Salah Azaiz, Tunis, Tunisie
| | - Amel Mezlini
- Service d'Oncologie Médicale, Institut Salah Azaiz, Tunis, Tunisie
| |
Collapse
|
20
|
Rachdi H, Mokrani A, Batti R, Ayadi M, Chraiet N, Mezlini A. Target therapy for metastatic breast cancer. Tunis Med 2018; 96:465-471. [PMID: 30430522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Breast cancer is the first cancer in women worldwide. Since the previous estimates of WHO in 2008, incidence is increasing and it is estimated that 30% of women will develop immediately a metastatic form. However, advances in molecular biology and the discovery of new therapies have extended significantly the survival of patients and improved the quality of life of patients with metastatic breast cancer. The study of gene expression and protein profile has resulted in a finer classification of breast cancer and adapt the treatment of patients according to their molecular profiles. The purpose of our work is to describe the different targeted therapies used in the MBC and their action's mechanism referring to various therapeutic trials described in the literature.
Collapse
|
21
|
Benna M, Slimane M, Smaoui W, Syrjanen K, Belaid A, Bouaziz H, Hechiche M, Benna F, Rahal K, Benhami M, El Kinany H, Ouahbi H, Amadour L, Ahllali I, Ben Brahim Z, Elmrabet FZ, Arifi S, Mellas N, Hashem W, Abd-Elkader Y, Mokrani A, Shehata MA, Baker El Khouly EA, Elkady NM, Yahyaoui Y, Meddeb K, Letaif F, Chraiet N, Ayadi M, Melzi A, Kessi Nora N, Abdelmalik F, Elfageih MA, Abdeljaoued S, Goucha A, El Mokh H, Ben Hassouna J, Gamoudi A, Ben Rekaya M, Hamdi Y, Laabidi S, Jaidane O, Ben Nasr S, Elbenna H, Mejri N, Daoud N, Ayari J, Balti M, Mighri N, Boujemaa M, Haddaoui A, Boussen H, Abdelhak S, Mashhour K, Safwat E, Kouadri N, Filali T, Tawfik EA, Elagizy HA, Berrazaga Y, Mokrani A, Gabsi A, Raies H, Melzi A, Derbouz Z, Henni Manseur S, Bounedjar A, Elrgig M, Abdalla AB, Bettaieb I, Adouni O, Bouzaiene H, Rahal K. Oral Communication Abstracts of the 18th Pan Arab Cancer Congress. TUNISIA. April 19-21, 2018. Tunis Med 2018; 96:183-258. [PMID: 30430521] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
|
22
|
Lagha A, Chraiet N, Ayadi M, Krimi S, Allani B, Rifi H, Raies H, Mezlini A. RETRACTED: Systemic therapy in the management of metastatic or advanced salivary gland cancers. Oral Oncol 2018; 78:229. [PMID: 29496053 DOI: 10.1016/j.oraloncology.2018.01.034] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- Aymen Lagha
- Department of medical oncology, Salah Azaiez Institute, Bab Saadoun Tunis Tunisia
| | - Nesrine Chraiet
- Department of medical oncology, Salah Azaiez Institute, Bab Saadoun Tunis Tunisia
| | - Mouna Ayadi
- Department of medical oncology, Salah Azaiez Institute, Bab Saadoun Tunis Tunisia
| | - Sarra Krimi
- Department of medical oncology, Salah Azaiez Institute, Bab Saadoun Tunis Tunisia
| | - Bassem Allani
- Department of medical oncology, Salah Azaiez Institute, Bab Saadoun Tunis Tunisia
| | - Hela Rifi
- Department of medical oncology, Salah Azaiez Institute, Bab Saadoun Tunis Tunisia
| | - Henda Raies
- Department of medical oncology, Salah Azaiez Institute, Bab Saadoun Tunis Tunisia
| | - Amel Mezlini
- Department of medical oncology, Salah Azaiez Institute, Bab Saadoun Tunis Tunisia
| |
Collapse
|
23
|
Bousrih C, Mokrani A, Ayadi M, Meddeb K, Yahyaoui Y, Letaief F, Chraiet N, Rais H, Mezlini A. Facteurs prédictifs de rechute locale au cours des rhabdomyosarcomes de l’orbite de l’enfant. Cancer Radiother 2017. [DOI: 10.1016/j.canrad.2017.08.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
24
|
Ayadi M, Gabsi A, Meddeb K, Mokrani A, Yahiaoui Y, Letaief F, Chraiet N, Rais H, Mezlini A. Primary leiomyosarcoma of thyroid gland: the youngest case. Pan Afr Med J 2017; 26:113. [PMID: 28533836 PMCID: PMC5429415 DOI: 10.11604/pamj.2017.26.113.11472] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2016] [Accepted: 02/02/2017] [Indexed: 12/21/2022] Open
Abstract
Primary leiomyosarcomas of the thyroid gland are extremely rare. We report a case of a 32 year-old women with a multinodular goiter. She underwent total thyroidectomy. The tumor histology showed spindle-shaped cells that expressed desmine, caldesmone and smooth muscle actine but were negative cytokeratins.
Collapse
Affiliation(s)
- Mouna Ayadi
- Service d'Oncologie Médicale, Institut Salah Azaiez Tunis, Faculté de Médecine de Tunis, Université el Manar, Tunisie
| | - Azza Gabsi
- Service d'Oncologie Médicale, Institut Salah Azaiez Tunis, Faculté de Médecine de Tunis, Université el Manar, Tunisie
| | - Khdija Meddeb
- Service d'Oncologie Médicale, Institut Salah Azaiez Tunis, Faculté de Médecine de Tunis, Université el Manar, Tunisie
| | - Amina Mokrani
- Service d'Oncologie Médicale, Institut Salah Azaiez Tunis, Faculté de Médecine de Tunis, Université el Manar, Tunisie
| | - Yosra Yahiaoui
- Service d'Oncologie Médicale, Institut Salah Azaiez Tunis, Faculté de Médecine de Tunis, Université el Manar, Tunisie
| | - Feryel Letaief
- Service d'Oncologie Médicale, Institut Salah Azaiez Tunis, Faculté de Médecine de Tunis, Université el Manar, Tunisie
| | - Nesrine Chraiet
- Service d'Oncologie Médicale, Institut Salah Azaiez Tunis, Faculté de Médecine de Tunis, Université el Manar, Tunisie
| | - Henda Rais
- Service d'Oncologie Médicale, Institut Salah Azaiez Tunis, Faculté de Médecine de Tunis, Université el Manar, Tunisie
| | - Amel Mezlini
- Service d'Oncologie Médicale, Institut Salah Azaiez Tunis, Faculté de Médecine de Tunis, Université el Manar, Tunisie
| |
Collapse
|
25
|
Mokrani A, Guermazi F, Yahyaoui Y, Hmida L, Doghri R, Ayadi M, Khedija M, Letaief F, Chraiet N, Raies H, Mrad K, Mezlini A. Giant Cell Tumor of Soft Tissues: A Case Report and Review of Literature. ACTA ACUST UNITED AC 2017. [DOI: 10.4172/1948-5956.1000474] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
26
|
Letaief F, Nasri M, Ayadi M, Meddeb K, Mokrani A, Yahyaoui Y, Chraiet N, Raies H, Mezlini A. Potential predictive factors for pathologic complete response after the neoadjuvant treatment of rectal adenocarcinoma: a single center experience. Cancer Biol Med 2017; 14:327-334. [PMID: 28884049 PMCID: PMC5570609 DOI: 10.20892/j.issn.2095-3941.2017.0037] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
OBJECTIVE : To assess the response rate of patients with rectal adenocarcinoma to neoadjuvant therapy and to identify the predictors of histological regression after neoadjuvant radiotherapy (RT) or concurrent chemoradiotherapy (CCRT). METHODS : This study recruited 64 patients. The patients had resectable cancer of the lower and the middle rectum (T3/T4 and/or N+) without distant metastasis and received neoadjuvant RT or CCRT followed by radical surgery with total mesorectal excision (TME) between January 2006 and December 2011. The patients were classified into non-response (NR), partial response (PR), and pathologic complete response (pCR) based on the Dworak tumor regression grading system. RESULTS : The median age of patients was 57 years (ranging from 22 to 85). A total of 24 patients were treated with neoadjuvant CCRT, whereas 40 patients were treated with RT alone. Abdominoperineal resection (APR) was performed on 29 patients (45%). Anterior resection with TME was performed on 34 patients (53%). One patient had local resection. Histologically, 12 (19%), 24 (73%), and 28 (44%) patients exhibited pCR, PR, and NR, respectively. Univariate analysis revealed that the predictors of tumor regression were as follows: the absence of lymph node involvement from initial imaging (cN0) (P=0.021); normal initial carcinoembryonic antigen (CEA) level (P=0.01); hemoglobin level ≥12 g/dl (P=0.009); CCRT (P=0.021); and tumor downstaging in imaging (P=0.001). Multivariate analysis showed that the main predictors of pCR were CT combined with neoadjuvant RT, cN0 stage, and tumor regression on imaging. CONCLUSIONS : Identifying the predictors of pCR following neoadjuvant therapy aids the selection of responsive patients for non-aggressive surgical treatment and possible surveillance.
Collapse
Affiliation(s)
- Feryel Letaief
- Department of Medical Oncology, Salah Azaïz Cancer Institute, Tunis 1006, Tunisia
| | - Meher Nasri
- Department of Medical Oncology, Salah Azaïz Cancer Institute, Tunis 1006, Tunisia
| | - Mouna Ayadi
- Department of Medical Oncology, Salah Azaïz Cancer Institute, Tunis 1006, Tunisia
| | - Khedija Meddeb
- Department of Medical Oncology, Salah Azaïz Cancer Institute, Tunis 1006, Tunisia
| | - Amina Mokrani
- Department of Medical Oncology, Salah Azaïz Cancer Institute, Tunis 1006, Tunisia
| | - Yosra Yahyaoui
- Department of Medical Oncology, Salah Azaïz Cancer Institute, Tunis 1006, Tunisia
| | - Nesrine Chraiet
- Department of Medical Oncology, Salah Azaïz Cancer Institute, Tunis 1006, Tunisia
| | - Henda Raies
- Department of Medical Oncology, Salah Azaïz Cancer Institute, Tunis 1006, Tunisia
| | - Amel Mezlini
- Department of Medical Oncology, Salah Azaïz Cancer Institute, Tunis 1006, Tunisia
| |
Collapse
|
27
|
Mghirbi F, Ayadi M, El Behi K, Letaief-ksontini F, Jmour O, Meddeb K, Mokrani A, Yahyaoui Y, Rais H, Chraiet N, Mezlini A. RM-016 Prognostic factors and assessment of postoperative chemoradiotherapy in gastric cancer. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw201.16] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
28
|
Chraiet N, Ben Romdhane Y, Serghini M, Raies H, Ayadi M, Meddeb K, Mokrani A, Yahyaoui Y, Filali A, Mezlini A. P-096 Gastric Carcinoma and curative surgery predictive factors: Retrospective analysis of 60 Tunisian cases. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv233.96] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
29
|
Lagha A, Labidi S, Chraiet N, Afrit M, Boussen H. Unusual and extensive presentation of Merkel cell carcinoma. Tunis Med 2014; 92:581-582. [PMID: 25815548] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
|
30
|
Lagha A, Chraiet N, Labidi S, Rifi H, Ayadi M, Krimi S, Allani B, Raies H, Touati S, Boussen H, Kochbati L, Mezlini A. Larynx preservation: what is the best non-surgical strategy? Crit Rev Oncol Hematol 2013; 88:447-58. [PMID: 23755889 DOI: 10.1016/j.critrevonc.2013.05.005] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2012] [Revised: 04/10/2013] [Accepted: 05/03/2013] [Indexed: 11/30/2022] Open
Abstract
The concept of larynx preservation in locally advanced laryngeal or hypopharyngeal squamous cell carcinoma has evolved during the last three decades, especially with the advancement of nonsurgical strategies. These nonsurgical strategies include: (1) radiotherapy alone; (2) concomitant chemoradiotherapy (CCRT); and (3) induction chemotherapy followed by radiotherapy or CCRT and concurrent anti-epidermal growth factor receptor (EGFR). To date, the best approach for larynx preservation has yet to be defined. In this article, we review and discuss important recent randomized phase II/III trials investigating larynx preservation in order to facilitate the selection of an appropriate strategy in the clinical setting. However, the decision of larynx preservation should always be a multidisciplinary approach.
Collapse
Affiliation(s)
- Aymen Lagha
- Department of Medical Oncology, Salah Azaiez Institute, Tunis, Tunisia.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Belaid I, Ayadi M, Rifi H, Chraiet N, Rais H, Mezlini A. Clinicopathological Features and Outcome of Primary Small Intestinal Lymphoma: Analysis of 210 Patients of a Single Institution. Ann Oncol 2013. [DOI: 10.1093/annonc/mdt202.20] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
32
|
Belaid I, Rais H, Rifi H, Chraiet N, Ayadi M, Mezlini A. Primary Intestinal T Cell Lymphoma in Tunisian Patients. Ann Oncol 2013. [DOI: 10.1093/annonc/mdt203.287] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
33
|
Lagha A, Ayadi M, Krimi S, Chraiet N, Allani B, Rifi H, Raies H, Mezlini A. Squamous Cell Carcinoma of the Vaginal Vault Following Whole Pelvic Radiation Therapy and Surgery. J Gynecol Surg 2013. [DOI: 10.1089/gyn.2012.0043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- Aymen Lagha
- Department of Medical Oncology, Salah Azaiez Institute, Tunis, Tunisia
| | - Mouna Ayadi
- Department of Medical Oncology, Salah Azaiez Institute, Tunis, Tunisia
| | - Sarra Krimi
- Department of Medical Oncology, Salah Azaiez Institute, Tunis, Tunisia
| | - Nesrine Chraiet
- Department of Medical Oncology, Salah Azaiez Institute, Tunis, Tunisia
| | - Bassem Allani
- Department of Medical Oncology, Salah Azaiez Institute, Tunis, Tunisia
| | - Hela Rifi
- Department of Medical Oncology, Salah Azaiez Institute, Tunis, Tunisia
| | - Henda Raies
- Department of Medical Oncology, Salah Azaiez Institute, Tunis, Tunisia
| | - Amel Mezlini
- Department of Medical Oncology, Salah Azaiez Institute, Tunis, Tunisia
| |
Collapse
|
34
|
Lagha A, Ayadi M, Krimi S, Chraiet N, Allani B, Rifi H, Raies H, Mezlini A. Primary anorectal melanoma: A case report with extended follow-up. Am J Case Rep 2012; 13:254-7. [PMID: 23569542 PMCID: PMC3615979 DOI: 10.12659/ajcr.883506] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2012] [Accepted: 05/10/2012] [Indexed: 12/02/2022]
Abstract
Background: Anorectal melanoma is a rare and aggressive disease. The mainstay of treatment is usually surgical with curative or palliative intent, since radio- and chemotherapy do not really improve the outcome. The poor prognosis is attributable to delay in diagnosis and its inherent biologic aggressiveness. Case Report: We present a case of anorectal melanoma in a 68-year-old man who underwent solely abdominoperineal amputation and was doing well 30 months after surgery, without any evidence of recurrent disease. Conclusions: Treatment of anorectal melanoma should be by the least morbid means possible. Surgical procedure that can achieve a complete local excision and respect the functional aspects and quality of life of the patient remains the best therapeutic approach. No systemic regimen for metastatic anorectal melanoma is considered standard of care.
Collapse
Affiliation(s)
- Aymen Lagha
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saadoun, Tunis, Tunisia
| | | | | | | | | | | | | | | |
Collapse
|
35
|
Lagha A, Chraiet N, Oueslati I, Krimi S, Ayadi M, Allani B, Rifi H, Raies H, Mezlini A. Schwannoma of the Breast: Presentation of Four Cases and Review of the Literature. J Gynecol Surg 2012. [DOI: 10.1089/gyn.2012.0045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- Aymen Lagha
- Department of Medical Oncology, Salah Azaiez Institute, Tunis, Tunisia
| | - Nesrine Chraiet
- Department of Medical Oncology, Salah Azaiez Institute, Tunis, Tunisia
| | - Imen Oueslati
- Department of Surgical Oncology, Salah Azaiez Institute, Tunis, Tunisia
| | - Sarra Krimi
- Department of Medical Oncology, Salah Azaiez Institute, Tunis, Tunisia
| | - Mouna Ayadi
- Department of Medical Oncology, Salah Azaiez Institute, Tunis, Tunisia
| | - Bassem Allani
- Department of Medical Oncology, Salah Azaiez Institute, Tunis, Tunisia
| | - Hela Rifi
- Department of Medical Oncology, Salah Azaiez Institute, Tunis, Tunisia
| | - Henda Raies
- Department of Medical Oncology, Salah Azaiez Institute, Tunis, Tunisia
| | - Amel Mezlini
- Department of Medical Oncology, Salah Azaiez Institute, Tunis, Tunisia
| |
Collapse
|
36
|
Lagha A, Chraiet N, Ayadi M, Krimi S, Allani B, Rifi H, Raies H, Mezlini A. Systemic therapy in the management of metastatic or advanced salivary gland cancers. Oral Oncol 2012; 48:948-957. [PMID: 22698431 DOI: 10.1016/j.oraloncology.2012.05.004] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2012] [Accepted: 05/02/2012] [Indexed: 11/17/2022]
Abstract
Salivary gland cancers are very rare tumors. They are characterized by a histologic heterogeneity and a poor outcome. According to this rarity, few prospective data are available to date. No standard recommendations could be held for the use of systemic therapy in these tumors. Several case reports and small studies have investigated the contribution of different agents of chemotherapy. With the extension of molecular biology approach in oncology several signaling pathways have been discovered in different cancers including salivary gland cancers; thus a number of targeted therapies have been investigated. This paper reviewed exhaustively the studies investigating the role of systemic therapies (chemotherapy, targeted therapy, hormone therapy) in salivary gland cancers.
Collapse
Affiliation(s)
- Aymen Lagha
- Department of Medical Oncology, Salah Azaiez Institute, Tunis, Tunisia.
| | - Nesrine Chraiet
- Department of Medical Oncology, Salah Azaiez Institute, Tunis, Tunisia
| | - Mouna Ayadi
- Department of Medical Oncology, Salah Azaiez Institute, Tunis, Tunisia
| | - Sarra Krimi
- Department of Medical Oncology, Salah Azaiez Institute, Tunis, Tunisia
| | - Bassem Allani
- Department of Medical Oncology, Salah Azaiez Institute, Tunis, Tunisia
| | - Hela Rifi
- Department of Medical Oncology, Salah Azaiez Institute, Tunis, Tunisia
| | - Henda Raies
- Department of Medical Oncology, Salah Azaiez Institute, Tunis, Tunisia
| | - Amel Mezlini
- Department of Medical Oncology, Salah Azaiez Institute, Tunis, Tunisia
| |
Collapse
|
37
|
Lagha A, Ayadi M, Chraiet N, Krimi S, Mokrani A, Rifi H, Raies H, Mezlini A. Central Nervous System Metastases in Epithelial Ovarian Carcinoma: Presentation of Four Cases and Review of the Literature. J Gynecol Surg 2012. [DOI: 10.1089/gyn.2011.0082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Aymen Lagha
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saâdoun, Tunis, Tunisia
| | - Mouna Ayadi
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saâdoun, Tunis, Tunisia
| | - Nesrine Chraiet
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saâdoun, Tunis, Tunisia
| | - Sarra Krimi
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saâdoun, Tunis, Tunisia
| | - Amina Mokrani
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saâdoun, Tunis, Tunisia
| | - Hela Rifi
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saâdoun, Tunis, Tunisia
| | - Henda Raies
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saâdoun, Tunis, Tunisia
| | - Amel Mezlini
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saâdoun, Tunis, Tunisia
| |
Collapse
|
38
|
Lagha A, Krimi S, Chraiet N, Ayadi M, Rifi H, Raies H, Mezlini A. Conservative Management in Primary Vaginal Lymphoma: Role of Chemotherapy. J Gynecol Surg 2012. [DOI: 10.1089/gyn.2011.0031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- Aymen Lagha
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saadoun, Tunis, Tunisia
| | - Sarra Krimi
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saadoun, Tunis, Tunisia
| | - Nesrine Chraiet
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saadoun, Tunis, Tunisia
| | - Mouna Ayadi
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saadoun, Tunis, Tunisia
| | - Hela Rifi
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saadoun, Tunis, Tunisia
| | - Henda Raies
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saadoun, Tunis, Tunisia
| | - Amel Mezlini
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saadoun, Tunis, Tunisia
| |
Collapse
|
39
|
Chraiet N, Lagha A, Krimi S, Ayadi M, Rifi H, Raies H, Mezlini A. Non-Hodgkin's Lymphoma Mimicking Gynecologic Malignancies of the Uterine Corpus, Cervix, and Vagina: A Report of Three Cases. J Gynecol Surg 2012. [DOI: 10.1089/gyn.2011.0047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- Nesrine Chraiet
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saadoun, Tunis, Tunisia
| | - Aymen Lagha
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saadoun, Tunis, Tunisia
| | - Sarra Krimi
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saadoun, Tunis, Tunisia
| | - Mouna Ayadi
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saadoun, Tunis, Tunisia
| | - Hela Rifi
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saadoun, Tunis, Tunisia
| | - Henda Raies
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saadoun, Tunis, Tunisia
| | - Amel Mezlini
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saadoun, Tunis, Tunisia
| |
Collapse
|
40
|
Karoui S, Debbabi A, Serghini M, Haouet S, Fenniche S, Chraiet N, Boubaker J, Mezlini A, Filali A. Coexistence of a malignant stromal tumor of the stomach with an adenocarcinoma of the lung in a patient with neurofibromatosis type 1. Tunis Med 2012; 90:264-266. [PMID: 22481202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
|
41
|
Lagha A, Chraiet N, Krimi S, Mahjoub N, Kochbati L, Ayadi M, Rifi H, Raies H, Belaid I, Mezlini A. Rectal Metastasis of Breast Carcinoma: Presentation of Two Cases. J Gynecol Surg 2012. [DOI: 10.1089/gyn.2011.0022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Aymen Lagha
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saadoun, Tunis, Tunisia
| | - Nesrine Chraiet
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saadoun, Tunis, Tunisia
| | - Sarra Krimi
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saadoun, Tunis, Tunisia
| | - Najet Mahjoub
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saadoun, Tunis, Tunisia
| | - Lotfi Kochbati
- Department of Radiotherapy, Salah Azaiez Institute, Bab Saadoun, Tunis, Tunisia
| | - Mouna Ayadi
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saadoun, Tunis, Tunisia
| | - Hela Rifi
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saadoun, Tunis, Tunisia
| | - Henda Raies
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saadoun, Tunis, Tunisia
| | - Imtinen Belaid
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saadoun, Tunis, Tunisia
| | - Amel Mezlini
- Department of Medical Oncology, Salah Azaiez Institute, Bab Saadoun, Tunis, Tunisia
| |
Collapse
|
42
|
Lagha A, Ayadi M, Largueche L, Krimi S, Chraiet N, Allani B, Rifi H, Raies H, Elmatri L, Mezlini A. Choroidal metastasis from breast cancer in a male patient treated successfully with systemic chemotherapy. ACTA ACUST UNITED AC 2012. [DOI: 10.5348/ijcri-2012-07-141-cr-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
43
|
Fehri R, Mahjoub N, Hentati D, Chraiet N, Rifi H, Kochbati L, Henda R. À propos de cinq cas de métastase cervicale d’adénocarcinome de primitif inconnu. Cancer Radiother 2011. [DOI: 10.1016/j.canrad.2011.07.093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
44
|
Ben Ammar CN, Kochbati L, Chraiet N, Amarouche A, Gargouri W, Ben Abdallah M, Besbes M, Maalej M. L'irradiation pariétale est-elle justifiée après mastectomie et curage négatif? Cancer Radiother 2006. [DOI: 10.1016/j.canrad.2006.09.048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|